106 related articles for article (PubMed ID: 24956487)
1. Enhanced cutaneous bioavailability of dehydroepiandrosterone mediated by nano-encapsulation.
Badihi A; Debotton N; Frušić-Zlotkin M; Soroka Y; Neuman R; Benita S
J Control Release; 2014 Sep; 189():65-71. PubMed ID: 24956487
[TBL] [Abstract][Full Text] [Related]
2. Dermal absorption behavior of fluorescent molecules in nanoparticles on human and porcine skin models.
Debotton N; Badihi A; Robinpour M; Enk CD; Benita S
Int J Pharm; 2017 May; 524(1-2):290-303. PubMed ID: 28373103
[TBL] [Abstract][Full Text] [Related]
3. Topical drug delivery by a polymeric nanosphere gel: Formulation optimization and in vitro and in vivo skin distribution studies.
Batheja P; Sheihet L; Kohn J; Singer AJ; Michniak-Kohn B
J Control Release; 2011 Jan; 149(2):159-67. PubMed ID: 20950659
[TBL] [Abstract][Full Text] [Related]
4. Formulation, characterization and evaluation of curcumin-loaded PLGA nanospheres for cancer therapy.
Mukerjee A; Vishwanatha JK
Anticancer Res; 2009 Oct; 29(10):3867-75. PubMed ID: 19846921
[TBL] [Abstract][Full Text] [Related]
5. Skin permeation study of dehydroepiandrosterone (DHEA) compared with its alpha-cyclodextrin complex form.
Ceschel GC; Mora PC; Lombardi Borgia S; Maffei P; Ronchi C
J Pharm Sci; 2002 Nov; 91(11):2399-407. PubMed ID: 12379925
[TBL] [Abstract][Full Text] [Related]
6. Flurbiprofen PLGA-PEG nanospheres: role of hydroxy-β-cyclodextrin on ex vivo human skin permeation and in vivo topical anti-inflammatory efficacy.
Vega E; Egea MA; Garduño-Ramírez ML; García ML; Sánchez E; Espina M; Calpena AC
Colloids Surf B Biointerfaces; 2013 Oct; 110():339-46. PubMed ID: 23743255
[TBL] [Abstract][Full Text] [Related]
7. Development of patches for the controlled release of dehydroepiandrosterone.
Minghetti P; Cilurzo F; Casiraghi A; Montanari L; Santoro A
Drug Dev Ind Pharm; 2001 Aug; 27(7):711-7. PubMed ID: 11694019
[TBL] [Abstract][Full Text] [Related]
8. Solubility and transdermal permeation properties of a dehydroepiandrosterone cyclodextrin complex from hydrophilic and lipophilic vehicles.
Ceschel G; Bergamante V; Maffei P; Lombardi Borgia S; Calabrese V; Biserni S; Ronchi C
Drug Deliv; 2005; 12(5):275-80. PubMed ID: 16188726
[TBL] [Abstract][Full Text] [Related]
9. Isotretinoin-loaded nanocapsules: stability and cutaneous penetration by tape stripping in human and pig skin.
Bettoni CC; Felippi CC; de Andrade C; Raffin RP; Jager A; Guterres SS; Costal TD
J Biomed Nanotechnol; 2012 Apr; 8(2):258-71. PubMed ID: 22515077
[TBL] [Abstract][Full Text] [Related]
10. Comparison of PLGA and lecithin/chitosan nanoparticles for dermal targeting of betamethasone valerate.
Özcan I; Azizoğlu E; Senyiğit T; Özyazici M; Özer Ö
J Drug Target; 2013 Jul; 21(6):542-50. PubMed ID: 23390922
[TBL] [Abstract][Full Text] [Related]
11. Enhancement of dehydroepiandrosterone solubility and bioavailability by ternary complexation with alpha-cyclodextrin and glycine.
Mora PC; Cirri M; Guenther S; Allolio B; Carli F; Mura P
J Pharm Sci; 2003 Nov; 92(11):2177-84. PubMed ID: 14603503
[TBL] [Abstract][Full Text] [Related]
12. High plasma levels and effective lymphatic uptake of docetaxel in an orally available nanotransporter formulation.
Nassar T; Attili-Qadri S; Harush-Frenkel O; Farber S; Lecht S; Lazarovici P; Benita S
Cancer Res; 2011 Apr; 71(8):3018-28. PubMed ID: 21363913
[TBL] [Abstract][Full Text] [Related]
13. Skin penetration behavior of lipid-core nanocapsules for simultaneous delivery of resveratrol and curcumin.
Friedrich RB; Kann B; Coradini K; Offerhaus HL; Beck RC; Windbergs M
Eur J Pharm Sci; 2015 Oct; 78():204-13. PubMed ID: 26215463
[TBL] [Abstract][Full Text] [Related]
14. A modified double-emulsion method for the preparation of daunorubicin-loaded polymeric nanoparticle with enhanced in vitro anti-tumor activity.
Liu J; Qiu Z; Wang S; Zhou L; Zhang S
Biomed Mater; 2010 Dec; 5(6):065002. PubMed ID: 20924138
[TBL] [Abstract][Full Text] [Related]
15. Penetration and distribution of PLGA nanoparticles in the human skin treated with microneedles.
Zhang W; Gao J; Zhu Q; Zhang M; Ding X; Wang X; Hou X; Fan W; Ding B; Wu X; Wang X; Gao S
Int J Pharm; 2010 Dec; 402(1-2):205-12. PubMed ID: 20932886
[TBL] [Abstract][Full Text] [Related]
16. Possibility for the development of cosmetics with PLGA nanospheres.
Ito F; Takahashi T; Kanamura K; Kawakami H
Drug Dev Ind Pharm; 2013 May; 39(5):752-61. PubMed ID: 22725249
[TBL] [Abstract][Full Text] [Related]
17. High bioavailability of dehydroepiandrosterone administered percutaneously in the rat.
Labrie C; Flamand M; Bélanger A; Labrie F
J Endocrinol; 1996 Sep; 150 Suppl():S107-18. PubMed ID: 8943794
[TBL] [Abstract][Full Text] [Related]
18. Poly (lactide-co-glycolide) acid nanoencapsulation of a synthetic coumarin: cytotoxicity and bio-distribution in mice, in cancer cell line and interaction with calf thymus DNA as target.
Bhattacharyya SS; Paul S; De A; Das D; Samadder A; Boujedaini N; Khuda-Bukhsh AR
Toxicol Appl Pharmacol; 2011 Jun; 253(3):270-81. PubMed ID: 21549736
[TBL] [Abstract][Full Text] [Related]
19. Cytotoxicity and apoptotic signalling cascade induced by chelidonine-loaded PLGA nanoparticles in HepG2 cells in vitro and bioavailability of nano-chelidonine in mice in vivo.
Paul A; Das S; Das J; Samadder A; Khuda-Bukhsh AR
Toxicol Lett; 2013 Sep; 222(1):10-22. PubMed ID: 23850776
[TBL] [Abstract][Full Text] [Related]
20. A novel nanovesicular carrier system to deliver drug topically.
Kakkar S; Kaur IP
Pharm Dev Technol; 2013; 18(3):673-85. PubMed ID: 22612232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
